Cargando…

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

OBJECTIVES: In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. The acceptance of submissions with ICERs higher than the threshold was assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffiths, Elizabeth A, Hendrich, Janek K, Stoddart, Samuel DR, Walsh, Sean CM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564087/ https://www.ncbi.nlm.nih.gov/pubmed/26366099 http://dx.doi.org/10.2147/CEOR.S87462

Ejemplares similares

Incremental Cost-effectiveness Thresholds for Policy Decision-makers
por: Al-Zakwani, Ibrahim
Publicado: (2022)

Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
por: Santoli, Giuseppe, et al.
Publicado: (2023)

Commentary: Evaluating affordability, cost-effectiveness, cost-utility, health economics, and incremental cost-effectiveness ratio of manual small-incision cataract surgery - The need of the hour
por: Tejaswini, Antarvedi, et al.
Publicado: (2022)

Incremental Cost of Prematurity by Week of Gestational Age
por: Walsh, Eileen M., et al.
Publicado: (2019)

Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology
por: Jayasundara, Kavisha, et al.
Publicado: (2017)

Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review
por: Iino, Haru, et al.
Publicado: (2022)

Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study
por: Ker, J A, et al.
Publicado: (2008)

Cost–effectiveness thresholds: pros and cons
por: Bertram, Melanie Y, et al.
Publicado: (2016)

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis
por: Versteegh, Matthijs
Publicado: (2016)

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
por: Guertin, Jason R, et al.
Publicado: (2015)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

Reaching culturally acceptable and adequate diets at the lowest cost increment according to income level in Brazilian households
por: Verly, Eliseu, et al.
Publicado: (2020)

The Higgs Portal Above Threshold
por: Craig, Nathaniel, et al.
Publicado: (2014)

Thresholds for the cost–effectiveness of interventions: alternative approaches
por: Marseille, Elliot, et al.
Publicado: (2015)

Cost-Effectiveness Threshold for Healthcare: Justification and Quantification
por: Yanovskiy, Moshe, et al.
Publicado: (2022)

Cost-effectiveness thresholds or decision-making threshold: a novel perspective
por: Sun, Lihua, et al.
Publicado: (2023)

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs
por: Saluja, Ronak, et al.
Publicado: (2021)

Cost-Effective Corrosion Detection Sensor for Above-Ground Oil and Gas Flowlines
por: Vahdati, Nader, et al.
Publicado: (2022)

Incremental costs of hospital-acquired complications in Alberta, Canada
por: Jackson, T, et al.
Publicado: (2011)

Increment Threshold Functions in Retinopathy of Prematurity
por: Hansen, Ronald M., et al.
Publicado: (2016)

The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
por: Perry-Duxbury, Megan, et al.
Publicado: (2021)

Antiproton interactions above threshold at LEAR
por: Kilian, K
Publicado: (1980)

Physics above the pp threshold at LEAR
por: Dalpiaz, P
Publicado: (1982)

Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With Cancer
por: Birch, Kelly, et al.
Publicado: (2023)

Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi
por: Vetrini, Damir, et al.
Publicado: (2018)

Incremental healthcare cost burden in patients with atrial flutter only
por: Kim, Kathryn M., et al.
Publicado: (2023)

What next after GDP-based cost-effectiveness thresholds?
por: Chi, Y-Ling, et al.
Publicado: (2020)

Determination of a cost-effectiveness threshold for cancer interventions in Iran
por: Safari, Hossein, et al.
Publicado: (2022)

A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
por: Gandjour, Afschin
Publicado: (2023)

Getting a head start: turn-of-the-month submission effect for accepted papers in management journals
por: Meng, Liang, et al.
Publicado: (2020)

Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data()
por: Laxy, Michael, et al.
Publicado: (2017)

New physical thresholds above M$_{W}$
por: Barbieri, Riccardo
Publicado: (1981)

Electron-positron annihilation above charm threshold
por: Barbieri, Riccardo, et al.
Publicado: (1975)

High-order above-threshold dissociation of molecules
por: Lu, Peifen, et al.
Publicado: (2018)

Cost comparison between spinal versus general anesthesia for hip and knee arthroplasty: an incremental cost study
por: Bailey, Jonathan G., et al.
Publicado: (2022)

The Costs and Cost-Effectiveness of Mass Treatment for Intestinal Nematode Worm Infections Using Different Treatment Thresholds
por: Hall, Andrew, et al.
Publicado: (2009)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Using Top‐down and Bottom‐up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale
por: Cunnama, Lucy, et al.
Publicado: (2016)

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
por: Holden, Sarah E, et al.
Publicado: (2011)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r8blbt86t9rmaoaf9avgpkj29r